Research by Hemera Scientists on Nature Immunology Review

Mar 28, 2025 | News

The study titled “Tumor-associated macrophages enhance tumor innervation and spinal cord repair”, to which our researchers contributed, was recently published by Nature Reviews Immunology—one of the most authoritative journals in the field of immunology and a global...

Interview with Hemera on Byoblu: Focus on Cell Therapies for Nerve Regeneration

Mar 17, 2025 | News, Videos

Byoblu interviews Professors Bifari and Locati, co-founders of Hemera, to explore the scientific foundations of our REMaST cell therapy for the treatment of acute spinal cord injuries. Hemera’s work, the result of years of research and innovation, is dedicated to...

Hemera Receives a “GO” in Phase 1 of the EIC Accelerator

Feb 11, 2025 | News

Hemera submitted its application to the first phase of the EIC Accelerator program, a European Union initiative designed to support SMEs and startups with highly innovative projects capable of creating new markets or transforming existing ones. We are pleased to...

Cytotherapy Mentions Hemera as One of the Most Promising Players in Cell Therapy

Jan 5, 2025 | News

Hemera was recently featured in Cytotherapy, the official journal of the International Society for Cell & Gene Therapy, as one of the most innovative global players in the field of cell therapy. The article, titled “Smart Cell Therapy: An Industry Perspective on...

Preprint Published: Hemera’s REMaST Research Marks a Breakthrough in Nerve Regeneration

Dec 23, 2024 | News

We are pleased to announce the preprint publication of the scientific article presenting the results of our groundbreaking research on the REMaST therapy, developed to promote the regeneration of damaged nervous tissue. The study highlights a previously unknown role...

Hemera Among the Top 8 Health Startups

Nov 22, 2024 | News

We are proud to announce that Hemera has been included in the list of the 8 emerging startups revolutionizing the healthcare sector, as reported by Milano Finanza. This recognition highlights our commitment to innovation and the development of advanced therapeutic...